GNPXVSSLS• 6 Months (Normalized)
GNPX vs SLS (Genprex Inc. vs SELLAS Life Sciences Group Inc.)
Showing Closing Date Range from Mar, 21 to Sep, 17, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GNPX Performance $3.35
-92.03%
Genprex Inc.
Normalized Baseline0.00%
SLS Performance $11.55
+110.68%
SELLAS Life Sciences Group Inc.
Normalized Baseline0.00%
Alpha Spread Margin SLS LEADS
-202.71%
SLS outperforming by 202.71%
GNPXSLS
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GNPX SLS
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | GNPX Price | GNPX Gain (%) | SLS Price | SLS Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 17, 2026 | $3.35 | -92.03% | $11.55 | +110.68% | -202.71% |
| Sep 16, 2026 | $3.41 | -91.88% | $11.66 | +112.77% | -204.65% |
| Sep 15, 2026 | $3.31 | -92.12% | $11.29 | +106.02% | -198.14% |
| Sep 14, 2026 | $3.45 | -91.79% | $11.73 | +114.05% | -205.84% |
| Sep 11, 2026 | $3.35 | -92.03% | $11.55 | +110.77% | -202.80% |
| Sep 10, 2026 | $3.35 | -92.03% | $13.49 | +146.17% | -238.20% |
| Sep 09, 2026 | $3.43 | -91.84% | $13.95 | +154.56% | -246.40% |
| Sep 08, 2026 | $3.54 | -91.58% | $13.96 | +154.74% | -246.32% |
| Sep 04, 2026 | $3.50 | -91.67% | $13.86 | +152.92% | -244.59% |
| Sep 03, 2026 | $3.43 | -91.85% | $13.70 | +150.00% | -241.85% |
| Sep 02, 2026 | $3.51 | -91.65% | $14.16 | +158.39% | -250.04% |
| Sep 01, 2026 | $3.55 | -91.55% | $13.22 | +141.24% | -232.79% |
| Aug 31, 2026 | $3.71 | -91.17% | $13.34 | +143.43% | -234.60% |
| Aug 28, 2026 | $3.67 | -91.27% | $13.21 | +141.06% | -232.33% |
| Aug 27, 2026 | $3.61 | -91.41% | $15.21 | +177.55% | -268.96% |
Page 1 of 9